Suchergebnisse - "Sarilumab"

PubPharm (57)

1

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

2

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19 : a systematic review and meta-analysis

enthalten in: Emerging microbes & infections | 2022

von Yu, S. | Koh, D. | Choi, M. | +4

3

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients : A systematic review and meta-analysis

enthalten in: Reviews in medical virology | 2022

von Peng, J. | Fu, M. | Mei, H. | +5

4

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation : the SARICOR Randomized Clinical Trial

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Merchante, N. | Cárcel, S. | Garrido-Gracia, J. | +17

5

A guide to immunotherapy for COVID-19

enthalten in: Nature medicine | 2022

von van de Veerdonk, F. | Giamarellos-Bourboulis, E. | Pickkers, P. | +12

6

Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema

enthalten in: Ophthalmology. Retina | 2022

von Deaner, J. | Jaffe, G. | Keenan, R. | +2

7

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19 : A network meta-analysis

enthalten in: PloS one | 2022

von Godolphin, P. | Fisher, D. | Berry, L. | +10

8

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients : further randomized controlled trials are warranted

enthalten in: Human cell | 2021

von Panda, A. | Padhi, S. | Pati, A. | +1

9

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

enthalten in: Thorax | 2021

von Khan, F. | Stewart, I. | Fabbri, L. | +4

10

Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials

enthalten in: International journal of clinical pharmacology and therapeutics | 2021

von Sung, Y. | Lee, Y.

1
2
3
4
5
6
Nächster »
[6]